Smallwood Wealth Investment Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Hold
41
﹤0.01% 391
2026
Q1
$2.08K Hold
41
﹤0.01% 408
2025
Q4
$1.21K Hold
41
﹤0.01% 417
2025
Q3
$1.06K Hold
41
﹤0.01% 433
2025
Q2
$1.13K Hold
41
﹤0.01% 444
2025
Q1
$1.16K Buy
+41
New +$1.46K ﹤0.01% 417

Other funds holding MRNA

Smallwood Wealth Investment Management's MRNA Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Moderna (MRNA) position steady in Q2 2026 at 41 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Smallwood Wealth Investment Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 348 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Smallwood Wealth Investment Management held 41 shares of Moderna worth $2.87K as of Q2 2026.
  • Smallwood Wealth Investment Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #391 holding.
  • Smallwood Wealth Investment Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 348 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.